FLT3 and acute lymphoblastic leukemia: Yang and colleagues demonstrated that epigenetic alterations with enhancer hijacking secondary to the deletion of the PAN3 gene (13q12.2) explain elevated FLT3 expression in B-ALL patients, particularly among those with hyperdiploidy or those who experienced relapse.